These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15173099)

  • 1. Reanalysis of cancer drugs: old drugs, new tricks.
    Vande Woude GF; Kelloff GJ; Ruddon RW; Koo HM; Sigman CC; Barrett JC; Day RW; Dicker AP; Kerbel RS; Parkinson DR; Slichenmyer WJ
    Clin Cancer Res; 2004 Jun; 10(11):3897-907. PubMed ID: 15173099
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies to optimize the use of targeted agents for tumor therapy.
    Becker JC; Ugurel S; Schrama D
    J Dtsch Dermatol Ges; 2008 Apr; 6(4):281-5. PubMed ID: 18205839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigational antibody-drug conjugates for hematological malignancies.
    Polson AG; Ho WY; Ramakrishnan V
    Expert Opin Investig Drugs; 2011 Jan; 20(1):75-85. PubMed ID: 21142808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical and clinical experience of antisense therapy for solid tumors.
    Webb MS; Zon G
    Curr Opin Mol Ther; 1999 Aug; 1(4):458-63. PubMed ID: 11713760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical development of targeted moledular cancer drugs].
    Zwierzina H; Borner M
    Onkologie; 2005 Oct; 28 Suppl 4():35-9. PubMed ID: 16205104
    [No Abstract]   [Full Text] [Related]  

  • 6. Q&A: Geoffrey Shapiro on phase I drug trials. Spoke with Suzanne Rose.
    Shapiro G
    Cancer Discov; 2013 Oct; 3(10):1089. PubMed ID: 24124216
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy?
    Bell IM
    J Med Chem; 2004 Apr; 47(8):1869-78. PubMed ID: 15055985
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteasome inhibitors in cancer therapy: lessons from the first decade.
    Orlowski RZ; Kuhn DJ
    Clin Cancer Res; 2008 Mar; 14(6):1649-57. PubMed ID: 18347166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response surface methodology and the design of clinical trials for the evaluation of cancer chemotherapy.
    Carter WH
    Cancer Treat Rep; 1985 Oct; 69(10):1049-53. PubMed ID: 4042084
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer chemotherapy.
    Secchi GC
    Ann Ital Med Int; 1990; 5(3 Pt 3):288-95. PubMed ID: 2081089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bladder cancer and new drugs].
    Massard C; Albouy B; Gross-Goupil M; Ravaud A
    Bull Cancer; 2010; 97 Suppl Cancer de la vessie():43-50. PubMed ID: 20534389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of glyciphosphoramide used alone and in combination with other drugs].
    Wang ZY
    Zhonghua Zhong Liu Za Zhi; 1984 Sep; 6(5):379-81. PubMed ID: 6398774
    [No Abstract]   [Full Text] [Related]  

  • 13. Food and Drug Administration requirements for approval of new anticancer drugs.
    Johnson JR; Temple R
    Cancer Treat Rep; 1985 Oct; 69(10):1155-9. PubMed ID: 4042094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Target population and predictive factors of survival and efficacy of anti-HER1/EGFR drugs].
    Cadranel J
    Rev Pneumol Clin; 2007 Jan; 63(1 Pt 2):2S10-1. PubMed ID: 17242637
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental basis of antileukaemic chemotherapy.
    Messner HA
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():20-5. PubMed ID: 2653504
    [No Abstract]   [Full Text] [Related]  

  • 16. Metronomic chemotherapy: teaching old drugs new tricks?
    Vogelzang N
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):432-3. PubMed ID: 16163217
    [No Abstract]   [Full Text] [Related]  

  • 17. Intra-arterial chemotherapy for bladder cancer: its results and future role.
    Kato T; Sato K; Abe R; Moriyama M
    Prog Clin Biol Res; 1988; 269():551-67. PubMed ID: 3293071
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs of choice for cancer chemotherapy.
    Med Lett Drugs Ther; 1991 Mar; 33(840):21-8. PubMed ID: 2002782
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving the evaluation of new cancer treatments: challenges and opportunities.
    Rothenberg ML; Carbone DP; Johnson DH
    Nat Rev Cancer; 2003 Apr; 3(4):303-9. PubMed ID: 12671669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer drug therapy.
    Durkin WJ
    Prim Care; 1992 Dec; 19(4):759-78. PubMed ID: 1465486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.